- Show all
- Alabama
- Alaska
- All United States
- Arizona
- Arkansas
- California
- Colorado
- Connecticut
- Delaware
- District of Columbia
- Florida
- Georgia
- Hawaii
- Idaho
- Illinois
- Indiana
- Iowa
- Kansas
- Kentucky
- Louisiana
- Maine
- Maryland
- Massachusetts
- Michigan
- Minnesota
- Mississippi
- Missouri
- Montana
- National
- Nebraska
- Nevada
- New Hampshire
- New Jersey
- New Mexico
- New York
- North Carolina
- North Dakota
- Ohio
- Oklahoma
- Oregon
- Pennsylvania
- Rhode Island
- South Carolina
- South Dakota
- Tennessee
- Texas
- Utah
- Vermont
- Virginia
- Washington
- West Virginia
- Wisconsin
- Wyoming
- December 6, 2021
Q&A: State Contraceptive Equity Laws
Read moreThe Affordable Care Act (ACA) requires most health insurance plans to provide coverage for a broad range of women’s preventive health services without cost-sharing, including all Food and Drug Administration (FDA)-approved methods of contraception. While this requirement is a welcome and significant step forward, gaps in comprehensive coverage remain,…
- April 27, 2021
NHeLP Comments on New Mexico Centennial Care 2.0 SMI Amendment
Read moreIn this application, New Mexico seeks to waive the Institutes for Mental Disease (IMD) exclusion, implement High Fidelity Wraparound Services for an initially limited group of children and youth, institute a Graduate Medical Education Program, and establish vaccine coverage for limited beneficiary categories. For a variety of reasons, NHeLP…
- December 3, 2020
NHeLP Comments on HHS Regulations Rule (aka SUNSET Rule)
Read moreIn the Regulations Rule, HHS seeks to retroactively impose a mandatory expiration date on an estimated 18,000 duly promulgated regulations. Even long-standing rules would be automatically rescinded unless they survive a complex process of assessment and review. Programs like Medicaid and the Children's Health Insurance Program (CHIP) could be…
- September 17, 2020
NHeLP comments on Approved Drug Products with Therapeutic Equivalence Evaluations (the “Orange Book”)
Read moreThe Orange Book is an important and informative drug resource for a range of stakeholders. In a request for comments, FDA seeks feedback on the types of people or entitles using the Orange Book, additional information and features to incorporate into the Orange Book, and therapeutic equivalence information. NHeLP…
- December 21, 2018
Comments Urging HIV Prevention Drug be Designated an ACA “A” Recommended Service
Read morePeople who are at risk for HIV can prevent infection by taking a daily medication - Pre Exposure Prophylaxis (PrEP). However, many cannot access PrEP due to its high cost. The Affordable Care Act (ACA) recognizes that even small investments in preventive screenings and services can yield significant cost…
